Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Sodium Valproate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Valproate manufacturer or Sodium Valproate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Valproate manufacturer or Sodium Valproate supplier.
PharmaCompass also assists you with knowing the Sodium Valproate API Price utilized in the formulation of products. Sodium Valproate API Price is not always fixed or binding as the Sodium Valproate Price is obtained through a variety of data sources. The Sodium Valproate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate, including repackagers and relabelers. The FDA regulates valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate supplier is an individual or a company that provides valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate active pharmaceutical ingredient (API) or valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate finished formulations upon request. The valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers may include valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate API manufacturers, exporters, distributors and traders.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate DMF (Drug Master File) is a document detailing the whole manufacturing process of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate active pharmaceutical ingredient (API) in detail. Different forms of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate DMFs exist exist since differing nations have different regulations, such as valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate DMF submitted to regulatory agencies in the US is known as a USDMF. valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate USDMF includes data on valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate Drug Master File in Japan (valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate JDMF) empowers valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate JDMF during the approval evaluation for pharmaceutical products. At the time of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate Drug Master File in Korea (valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate. The MFDS reviews the valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate KDMF as part of the drug registration process and uses the information provided in the valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate KDMF to evaluate the safety and efficacy of the drug.
After submitting a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with KDMF on PharmaCompass.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP of the European Pharmacopoeia monograph is often referred to as a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate Certificate of Suitability (COS). The purpose of a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate to their clients by showing that a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP has been issued for it. The manufacturer submits a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP (COS) as part of the market authorization procedure, and it takes on the role of a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP holder for the record. Additionally, the data presented in the valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate DMF.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with CEP (COS) on PharmaCompass.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate written confirmation (valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate WC) is an official document issued by a regulatory agency to a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate manufacturer, verifying that the manufacturing facility of a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate APIs or valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate finished pharmaceutical products to another nation, regulatory agencies frequently require a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate WC (written confirmation) as part of the regulatory process.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate suppliers with NDC on PharmaCompass.
valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate GMP manufacturer or valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate GMP API supplier for your needs.
A valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CoA (Certificate of Analysis) is a formal document that attests to valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate's compliance with valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate specifications and serves as a tool for batch-level quality control.
valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CoA mostly includes findings from lab analyses of a specific batch. For each valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate may be tested according to a variety of international standards, such as European Pharmacopoeia (valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate EP), valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (valproate Sodium, Depakene, Valproate, Valrelease, Sodium valproate USP).
